Developing Nepal’s medicines pricing policy: evidence synthesis and stakeholders’ consultation

The objectives of this paper were to explore stakeholders’ opinions regarding Nepal’s existing medicines pricing practices/situation and build and present a set of medicines pricing policies for Nepal. A review of the literature and visits to various pharmacies and distributor outlets in Kathmandu were conducted to assess medicine pricing. Preliminary meetings with stakeholders led to the preparation of a draft interview guide. In January 2023, consultative sessions were held with representatives from several organizations, including the Department of Drug Administration and the Ministry of Health and Population.

The study authors found that stakeholders generally support price regulation, provided it undergoes periodic review, and both importers and the Ministry of Health and Population advocate for an independent body to regulate medicine prices. Suggested policy options for Nepal include cost-plus pricing, external and internal price referencing, and mark-up regulations. Key pricing issues identified indicate the need for transparent, rational, and updated regulations, which could inform a fair pricing structure and improve access to medicines.